Loading…
Loading…
More than 75% of LeqembiÂ-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEAD
LEQEMBIÂ Real-World LEADER Study Presented at AAICÂ 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable a
Barings Corporate Investors remains a top long-term performer among floating-rate CEF peers, but recent premium declines have pressured share price returns. The MCI's distribution yield is a hefty 9.01%, yet coverage has slipped as Fed rate cuts reduced portfolio income, raising the risk of a payout cut. While MCI's track record and NAV resilience support long-term holding, near-term caution is warranted given the risk of a distribution reduction that tends to lead to downside pressure.
Johnson and Johnson presents new IMAAVYÂ (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained dise
Barings Corporate Investors remains a hold as valuation improves, but risks rise amid a shifting macro environment. MCI's 9% yield is unsustainable, with payouts exceeding net investment income; a dividend cut is likely within twelve months. Rising interest rates and concentrated exposure to below-investment-grade, private bank loans heighten default and NAV erosion risk for MCI.
We will explain how to structure a new retirement portfolio in today's highly volatile market for sustainable income. We will present a balanced portfolio of funds and individual stocks with an initial yield of 5.7%. The portfolio presents 5 funds, supplemented with 10 individual stocks that offer reasonable growth, high income, and wide diversification.
Allegiant Adds Eight New Nonstop Routes, Expanding Service to Florida PR Newswire LAS VEGAS, May 19, 2026
CHARLOTTE, N.C.--(BUSINESS WIRE)--The Board of Trustees of Barings Corporate Investors (NYSE: MCI) (the "Trust") met on May 14, 2026, and would like to report its preliminary financial results for the first quarter of 2026. Financial Highlights(1) Three Months Ended March 31, 2026 Three Months Ended December 31, 2025 Total Amount Per Share(5) Total Amount Per Share(4) Net investment income(2) $ 6,152,365 $0.30 $ 6,033,700 $ 0.29 Net realized gains / (losses)(3) $ (2,022,928) $(0.10) $ 199,709.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for MCI and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.